Page 28 - Amgen News Today

Rhenman & Partners Asset Management AB purchased a new position in shares of Amgen Inc. (NASDAQ:AMGN – Free Report) in the 4th quarter, according to the company in its most recent filing with the SEC. The institutional investor purchased 4,500 shares of the medical research company’s stock, valued at approximately $1,296,000. Several other large investors […]

Rafferty Asset Management LLC grew its position in Amgen Inc. (NASDAQ:AMGN – Free Report) by 3.8% in the 4th quarter, Holdings Channel.com reports. The fund owned 127,129 shares of the medical research company’s stock after acquiring an additional 4,684 shares during the quarter. Rafferty Asset Management LLC’s holdings in Amgen were worth $36,616,000 as of […]

The Manufacturers Life Insurance Company lowered its holdings in shares of Amgen Inc. (NASDAQ:AMGN – Free Report) by 1.0% during the 4th quarter, Holdings Channel.com reports. The firm owned 586,841 shares of the medical research company’s stock after selling 6,144 shares during the quarter. The Manufacturers Life Insurance Company’s holdings in Amgen were worth $169,022,000 […]

Eagle Asset Management Inc. raised its position in Amgen Inc. (NASDAQ:AMGN – Free Report) by 35.4% in the 4th quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 483,831 shares of the medical research company’s stock after purchasing an additional 126,503 shares during the period. Eagle Asset Management […]

Eagle Asset Management Inc. boosted its stake in Amgen Inc. (NASDAQ:AMGN – Free Report) by 35.4% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 483,831 shares of the medical research company’s stock after buying an additional 126,503 shares during the quarter. Eagle […]

Banco BTG Pactual S.A. raised its holdings in shares of Amgen Inc. (NASDAQ:AMGN – Free Report) by 12.5% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 2,174 shares of the medical research company’s stock after purchasing an additional 241 shares […]

Although Krazati showed a statistically significant benefit in PFS, the FDA might question its clinical meaningfulness.

These stocks are trading at sky-high valuations which could make them vulnerable to sell-offs.

What Is the Dow 30? The Dow 30, commonly referred to as the "Dow," or the "Dow Jones In roobet vpn free

Burkett Financial Services LLC acquired a new position in shares of Amgen Inc. (NASDAQ:AMGN – Free Report) in the 4th quarter, Holdings Channel reports. The fund acquired 2,096 shares of the medical research company’s stock, valued at approximately $604,000. Amgen accounts for approximately 0.3% of Burkett Financial Services LLC’s portfolio, making the stock its 28th […]